临床肿瘤学
医学
人表皮生长因子受体2
指南
乳腺癌
肿瘤科
癌症
表皮生长因子受体
内科学
病理
妇科
作者
Stuart J. Schnitt,Paolo Tarantino,Laura C. Collins
标识
DOI:10.5858/arpa.2023-0187-ed
摘要
1 provide an update to the American Society of Clinical Oncology (ASCO)-College of American Pathologists (CAP) guideline for human epidermal growth factor receptor 2 (HER2) testing that specifically addresses the identification of "HER2-low" breast cancers, that is, those tumors that exhibit an immunohistochemistry (IHC) score of 1þ or 2þ without gene amplification using the 2018 ASCO-CAP HER2 guideline criteria.1,2
科研通智能强力驱动
Strongly Powered by AbleSci AI